U.S. ‘Pauses’ Johnson & Johnson Vaccine After Clotting Reports
The U.S. is recommending a “pause” in administrating the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.
In a joint statement Tuesday, the CDC and FDA said it was investigating clots and reduced platelet counts in six women post-vaccination.
All six were women between the ages of 18 and 48; one died and a second is hospitalized in critical condition. More than 6.8 million doses of the J&J vaccine have been administered in the U.S.
Click here to read more from the CDC.
IMPORTANT VACCINE UPDATE:
— Governor Phil Murphy (@GovMurphy) April 13, 2021
💉 J&J vaccine appointments will be cancelled or put on hold at all New Jersey vaccination sites until further notice
💉 @NJDeptofHealth will work with all vaccination sites to make arrangements for the administration of an alternative 2-dose vaccine https://t.co/p19v7WF9HL
